^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SH1573

    i
    Other names: SH1573, SH 1573, SH-1573
    Associations

    News

    Trials
    Company:
    Nanjing Sanhome Pharma
    Drug class:
    IDH2 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over3years
    A Phase 1 Study of SH1573 Capsules in Subjects With Refractory or Relapsed Acute Myelogenous Leukemia (clinicaltrials.gov)
    P1, N=41, Recruiting, Nanjing Sanhome Pharmaceutical, Co., Ltd.
    Clinical • New P1 trial
    |
    IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2) • UGT1A1 (UDP glucuronosyltransferase family 1 member A1)
    |
    IDH2 mutation • UGT1A1*1*1
    |
    SH1573